Key WordS37kDa/67kDa laminin receptor, LRP/LR, prion, PrP, TSE-therapy
AbbrevIAtIonS
CJDCreutzfeldt
AbStrACtWe identified the 37kDa/67kDa laminin receptor (LRP/LR) as a cell surface receptor for the cellular prion protein (PrP c ) and the infectious prion protein (PrP Sc ). Recently, we showed that anti-LRP/LR antibody W3 cured scrapie infected N2a cells. Here, we demonstrate that W3 delivered by passive immunotransfer into C57BL/6 mice reduced the PrP Sc content in the spleen significantly by 66%, demonstrating an impairment of the peripheral PrP Sc propagation. In addition, we observed a 1.8-fold increase in survival of anti-LRP/LR antibody W3 treated mice (mean survival of 31 days) compared to preimmune serum treated control animals (mean survival of 17 days). We conclude that the significant effect of anti-LRP/LR antibody W3 on the reduction of peripheral PrP Sc propagation might be due to the blockage of the prion receptor LRP/LR which is required, as previously shown in vitro, for PrP Sc propagation in vivo.